| Literature DB >> 27826279 |
Emanuela Saita1, Chiara Acquati2, Sara Molgora1.
Abstract
The positive outcomes associated with Patient Engagement (PE) have been strongly supported by the recent literature. However, this concept has been marginally addressed in the context of cancer. Limited attention has also received the role of informal caregivers in promoting physical and psychological well-being of patients, as well as the interdependence of dyads. The Cancer Dyads Group Intervention (CDGI) is a couple-based psychosocial intervention developed to promote engagement in management behaviors, positive health outcomes, and the quality of the relationship between cancer patients and their informal caregivers. The article examines the ability of the CDGI to promote adaptive coping behaviors and the perceived level of closeness by comparing cancer patients participating in the intervention and patients receiving psychosocial care at usual. Results indicate that individuals diagnosed with cancer attending the CDGI present significant increases in Fighting Spirit and Avoidance, while reporting also reduced levels of Fatalism and Anxious Preoccupation. Initial indications suggest that the intervention may contribute to strengthening the relationship with the primary support person.Entities:
Keywords: cancer; caregiver; engagement; group-based intervention; patient
Year: 2016 PMID: 27826279 PMCID: PMC5079095 DOI: 10.3389/fpsyg.2016.01660
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
An overview of the Cancer Dyads Group Intervention.
| The Cancer Dyads Group Intervention (CDGI) is a supportive group-based intervention for cancer patient and caregiver dyads theoretically inspired by the Bio-psychosocial Model (Engel, |
| The Symbolic Relational Model is the second theoretical foundation of the intervention. It is aimed at investigating family relations by focusing on the connection existing between individuals and family members (Cigoli and Scabini, |
| Furthermore, the decision to use the group as a clinical tool is supported by the psychoanalytic concept of “group thought,” which refers to the experience of thinking together (Neri, |
| The influence of these theoretical models has shaped and informed the techniques used in the meetings with the participants. The CDGI is organized in eight sessions and the group meets every 2 to 3 weeks for a couple of hours in a conference room of the hospital where patients are treated and where they have been recruited. Every session deals with a specific topic and begins with an exercise aimed at identifying and strengthening new coping repertoires of the dyad. The product of each exercise is later shared with the rest of the group to promote patients' and caregivers' closeness, and a sense of belonging among the participants. Two practitioners with extensive knowledge and experience in psychosocial oncology are the facilitators of the program. More practically, in collaboration with the multidisciplinary team individuals receiving care at the participating institutions are invited to participate. The group usually begins when enough dyads are recruited, from a minimum of 6 to a maximum of 10 participants. A brief overview of the CDGI is presented in the next paragraphs, while a more detailed presentation is available in a previous work (Saita et al., |
| The first session is aimed at facilitating the identification of the individual's coping strategies and to develop bonds among the members of the group, and with the two conductors. After the participants are introduced to each other, the facilitators present and read the stories of two cancer patients presenting opposite coping styles: active versus avoidance and denial. By comparing their own experiences with the two proposed stories, participants are encouraged to explore the concept of coping with cancer and to recognize their own coping strategy. This is also the moment when the facilitators introduce the idea that the coping process involves the partner or significant others; a strategy to bring the concept of dyadic coping in the setting of the intervention (Acitelli and Badr, |
| The session is focused on enhancing patients and caregivers' understanding of the illness. By involving a physician, it is possible for the participants to increase their knowledge about the diagnosis, treatment consequences, and overall impact on the quality of life. This is a crucial moment not only to clarify what are resources available to the patient, but also because the presence of the physician offers the opportunity to engage in an open communication which promotes the patient-provider relationship and their interaction becomes more meaningful and authentic. This meeting is divided in three main phases. In the first part, patients and caregivers can express their concerns about cancer, its treatment, and the overall cancer care continuum. The second phase involves the presence of the oncologist, who is invited to join the group to answer questions prepared by the participants or issues emerged in the first part of the meeting. This moment is particularly important to reduce the stress and uncertainty associated with cancer; especially for patients whose diagnosis is less common in the literature. Finally, dyads are invited to reflect together on the illness, to share thoughts, emotions, and concerns connected with the management of the disease. In particular, attention is given to concerns and challenges as well as to their hopes for the future. |
| Cancer requires the patient and the caregiver to assume new roles within the family and the relational system, with significant adjustments of the dynamics of giving and receiving care. Hence, the third session focuses on the change introduced by the diagnosis (participants are usually at the beginning the active treatment phase when they attend the intervention). Each dyad is invited to identify differences between the time before and after cancer, and later these topics are shared with the group. The clinical work of the two conductors is aimed at supporting the verbalization of concerns and aspects of change connected not only to the management of the illness, but more importantly to their relationship and the link with the supportive network (family members, close friends, colleagues); aspects which are often very difficult to verbalize and to process. As a consequence, therapists are attentive to feelings of uncertainty, resentment, denial, and inability to manage the demands of the illness. By offering participants a safe space to allow these feelings and concerns to emerge and to be shared with others facing the same stressor, it follows that participants become more aware of the impact of the illness on the life experiences of the patients, but also on the lives of caregivers, partners and family members. |
| Continuing the work to highlight the dyad's ability to engage in behaviors that facilitate a more beneficial adaptation to the cancer, as well as the relevance each other has for their well-being, the fourth session use the genogram (McGoldrick et al., |
| The fifth session deepens participants' understanding of how relationships can become resources during the cancer experience by using the instrument of a family coat of arms. After providing some example, every dyad is asked to draw a coat of arms that would represent their family and its key features (some participants have even added a motto that summarized their strength and resources). The goal of the exercise is to discover positive aspects, resources and competencies already available within their close relationships, so that no resource is lost during this time of need. |
| The core element of this meeting is the body and its transformation as a consequence of the illness, offering both patients and caregivers the opportunity to reflect about the beauty and strengths still present despite the negative impact of the treatment and its side effect on the body image of the patient. Using a photo-elicitation technique, each patient is invited to choose one image (from a set of 20) representing famous statues of female or male bodies (for examples the Donatello's David or the Venus de Milo), then each dyad is invited to write about the emotions associated to the image and to explore the meanings for his/her life experience. These products, which are then shared with the other participants, contribute to the discussion about body image and to the impact of cancer on intimate relationship and intimacy. |
| Session seven focuses on the concept of mindfulness. It begins with a brief relaxation exercise which can be completed without any specific support (a chair is enough). Subjects are given instructions to repeat the exercise outside the setting of the intervention. The relaxation exercise introduces a reflection about the mind-body connection and the reciprocal influence, aimed at identifying strategies to handle negative emotions and the stress experienced as the end of the treatment nears. This session ends with the request to each dyad to select or create an object that symbolizes what experienced during the program and to bring it to the last session. The facilitators do the same, by selecting an object that denotes their experience as well. |
| The last session begins with the presentation of the objects the dyads have chosen or created, to support the dyad making meaning of the experience while also bringing closure to the intervention. Then, each participant is given the opportunity to verbalize what the group and the contents of the sessions may have done for him/her. Symbolically, the session ends with diplomas presented to every dyad and with a gift from the facilitators. |
CDGI Pre-post test comparison.
| Fighting spirit | Pre-test | 2.99 | 0.79592 | −2.308 | −0.84150 | −0.03350 | |
| Post-test | 3.43 | 0.50091 | |||||
| Hopelessness/Helplessness | Pre-test | 1.67 | 0.55812 | −2.844 | −1.40003 | −0.20059 | |
| Post-test | 2.47 | 0.79120 | |||||
| Fatalism | Pre-test | 2.96 | 0.64174 | 3.424 | 0.411759 | 1.769491 | |
| Post-test | 1.87 | 0.818325 | |||||
| Anxious preoccupation | Pre-test | 2.14 | 0.52599 | 3.402 | 0.077864 | 0.339011 | |
| Post-test | 1.93 | 0.648717 | |||||
| Avoidance | Pre-test | 2.39 | 0.59139 | −4.652 | −0.934138 | −0.347112 | |
| Post-test | 3.03 | 0.442672 | |||||
Bold values indicates significant results.
Control Group Pre-post test comparison.
| Fighting spirit | Pre-test | 2.77 | 0.63038 | −1.327 | 0.194 | −0.45831 | 0.09654 |
| Post-test | 2.95 | 0.61335 | |||||
| Hopelessness/Helplessness | Pre-test | 1.86 | 0.60824 | −2.410 | −0.96772 | −0.08169 | |
| Post-test | 2.38 | 1.01721 | |||||
| Fatalism | Pre-test | 2.70 | 0.69186 | 4.537 | 0.467034 | 1.226496 | |
| Post-test | 1.86 | 0.735365 | |||||
| Anxious preoccupation | Pre-test | 2.09 | 0.70088 | 0.880 | 0.385 | −0.153928 | 0.388772 |
| Post-test | 1.97 | 0.556457 | |||||
| Avoidance | Pre-test | 2.67 | 0.87083 | −0.352 | 0.727 | −0.478033 | 0.337150 |
| Post-test | 2.74 | 0.715798 | |||||
Bold values indicates significant results.
Pre-test comparison by cancer type.
| CDGI | Fighting spirit | Breast cancer | 3.29 | 0.70550 | 0.17549 | 1.73542 | ||
| Rare Tumor | 2.34 | 0.58885 | 0.19381 | 1.71710 | ||||
| Hopelessness/Helplessness | Breast cancer | 1.46 | 0.40268 | −1.22514 | −0.14268 | |||
| Rare tumor | 2.15 | 0.60063 | −1.41430 | 0.04648 | ||||
| Fatalism | Breast cancer | 3.21 | 0.59635 | 0.20947 | 1.42689 | |||
| Rare tumor | 2.40 | 0.28284 | 0.34622 | 1.29014 | ||||
| Anxious preoccupation | Breast cancer | 2.12 | 0.61938 | −0.25 | 0.74 | −0.70127 | 0.55563 | |
| Rare tumor | 2.19 | 0.27181 | −0.55076 | 0.40513 | ||||
| Avoidance | Breast cancer | 2.43 | 0.52549 | 0.40 | 0.69 | −0.57228 | 0.83591 | |
| Rare tumor | 2.30 | 0.77862 | −0.81509 | 1.07873 | ||||
| Control Group | Fighting spirit | Breast cancer | 3.03 | 0.58535 | 0.42533 | 1.18534 | ||
| Rare tumor | 2.22 | 0.27372 | 0.50522 | 1.10545 | ||||
| Hopelessness/Helplessness | Breast cancer | 1.67 | 0.53597 | −0.98894 | −0.16545 | |||
| Rare tumor | 2.25 | 0.58392 | −1.01474 | −0.13964 | ||||
| Fatalism | Breast cancer | 2.91 | 0.68444 | 0.16479 | 1.10857 | |||
| Rare tumor | 2.27 | 0.49736 | 0.21151 | 1.06185 | ||||
| Anxious preoccupation | Breast cancer | 2.03 | 0.79625 | −0.69 | 0.492 | −0.70749 | 0.34753 | |
| Rare tumor | 2.21 | 0.44962 | −0.61719 | 0.25724 | ||||
| Avoidance | Breast cancer | 2.89 | 0.93844 | 0.05553 | 1.28487 | |||
| Rare tumor | 2.22 | 0.48047 | 0.17412 | 1.16628 | ||||
Bold values indicates significant results.
Post-test comparison by cancer type.
| CDGI | Fighting spirit | Breast cancer | 3.67 | 0.33344 | 0.37573 | 1.17882 | ||
| Rare tumor | 2.90 | 0.37914 | 0.31064 | 1.24390 | ||||
| Hopelessness/Helplessness | Breast cancer | 2.86 | 0.58485 | 0.60317 | 1.86411 | |||
| Rare tumor | 1.63 | 0.42953 | 0.65690 | 1.81037 | ||||
| Fatalism | Breast cancer | 1.48 | 0.666742 | −1.912 | −0.555328 | |||
| Rare tumor | 2.72 | 0.303315 | −1.753 | −0.713319 | ||||
| Anxious preoccupation | Breast cancer | 1.88 | 0.744678 | −0.45 | 0.65 | −0.934735 | 0.607462 | |
| Rare tumor | 2.05 | 0.410792 | −0.789682 | 0.462409 | ||||
| Avoidance | Breast cancer | 3.09 | 0.314498 | 0.78 | 0.44 | −0.327733 | 0.709551 | |
| Rare tumor | 2.90 | 0.675463 | −0.632810 | 1.014628 | ||||
| Control Group | Fighting spirit | Breast cancer | 3.02 | 0.68621 | 1.00 | 0.32 | −0.23184 | 0.68401 |
| Rare tumor | 2.80 | 0.40927 | −0.15970 | 0.61187 | ||||
| Hopelessness/Helplessness | Breast cancer | 2.90 | 0.79322 | 1.06471 | 2.10328 | |||
| Rare tumor | 1.31 | 0.40415 | 1.16541 | 2.00258 | ||||
| Fatalism | Breast cancer | 1.48 | 0.450557 | −1.521 | −0.772675 | |||
| Rare tumor | 2.63 | 0.598787 | −1.5795 | −0.714950 | ||||
| Anxious preoccupation | Breast cancer | 1.91 | 0.492031 | −0.90 | 0.37 | −0.600940 | 0.232482 | |
| Rare tumor | 2.09 | 0.681147 | −0.673038 | 0.304580 | ||||
| Avoidance | Breast cancer | 2.77 | 0.635979 | 0.25 | 0.80 | −0.476157 | 0.608370 | |
| Rare tumor | 2.70 | 0.893156 | −0.573572 | 0.705786 | ||||
Bold values indicates significant results.
Figure 1Pretest/Posttest comparision of the mean value of closeness for individuals in the CDGI.
Figure 2Pretest/Posttest comparision of the mean value of closeness for the control group.